Supported by: Medicine by Design’s Convergent Working Groups Award, The Allan Slaight Breakthrough Fund, OICR and Princess Margaret Cancer Centre, UHN
March 27, 2023, 8 a.m.-5:15 p.m. ET | MaRS Discovery District Auditorium, Toronto, Ontario
ABOUT THE FORUM
Thank you for joining us!
Please join us on March 27, 2023 at the RNA Nanomedicine for Regenerative Medicine and Cancer Breakthrough Forum, supported by Medicine by Design’s Convergent Working Groups Award, The Allan Slaight Breakthrough Fund, the Ontario Institute for Cancer Research and the Princess Margaret Cancer Centre, University Health Network. The forum will be hosted in person at the MaRS Discovery District Auditorium in Toronto, Ontario.
RNA-based technology, including mRNA vaccines and other therapeutics, have had a tremendous impact on human health recently, especially through the advent of mRNA-based COVID vaccines. Ontario has considerable expertise in this field, and we are making a big push to be a global leader in developing novel RNA-based medicines that will benefit our healthcare system and help millions of people around the globe. At this forum, we will address questions around the status of technology behind RNA therapeutics, critical gaps in knowledge and barriers to clinical adoption of RNA nanomedicine. These questions will revolve around selective targeting, personalization of therapy and strategies for moving these therapies safely to the clinic.
The day's agenda will be split equally between regenerative medicine and cancer-specific talks and panel discussions, featuring many esteemed international and local speakers.
Don’t miss this opportunity to learn about where RNA research is headed and help shape its future in Ontario. Registration is free and open to all.
Event Co-Chairs
Mamatha Bhat
Staff Hepatologist & Clinician-Scientist, Ajmera Transplant Program, UHN
Hansen He
Senior Scientist, Princess Margaret Cancer Centre
Bowen Li
Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
Laszlo Radvanyi
President & Scientific Director, Ontario Institute for Cancer Research
Gang Zheng
Senior Scientist & Associate Research Director, Princess Margaret Cancer Centre
Program Committee
Warren Chan
Professor, Canada Research Chair in Nanobioengineering & Director, University of Toronto
Haissi Cui
Assistant Professor, Biological Chemistry, University of Toronto
Elmar Jaeckel
Medical Director, Liver Transplant Program, University Health Network
Bo Wang
Lead Artificial Intelligence Scientist, Peter Munk Cardiac Centre and the Techna Institute , UHN
EVENT SUPPORTERS
Working Together
This event is part of the University of Toronto’s Medicine by Design initiative, which receives funding from the Canada First Research Excellence Fund (CFREF).
